Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Landmark perspective: Landmarks in viral hepatitis.

S Sherlock

    JAMA
    |July 20, 1984
    PubMed
    Summary

    Viral hepatitis research has advanced significantly, distinguishing Hepatitis A and B. Hepatitis B virus integration into host DNA can cause liver cancer, while other hepatitis causes remain unidentified.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis.

    Clinics in liver disease·2001
    Same author

    A la carte interferon for hepatitis C?

    Hepatology (Baltimore, Md.)·2000
    Same author

    The hepatic flaviviridae: summary.

    Journal of viral hepatitis·2000
    Same author

    Biotechnologies and liver diseases.

    Forum (Genoa, Italy)·1999
    Same author

    Carbon dioxide embolism following diagnostic hysteroscopy.

    Anaesthesia and intensive care·1999
    Same author

    Focal nodular hyperplasia in a young female.

    Journal of hepatology·1999

    Area of Science:

    • Virology
    • Hepatology
    • Molecular Biology

    Background:

    • Pioneering work by Krugman and Blumberg differentiated viral hepatitis types (A and B) and identified Australia antigen.
    • Hepatitis A virus (HAV) has been cultured, its structure elucidated, and acute disease diagnosis established.
    • Hepatitis B virus (HBV) molecular biology advancements led to vaccine development and understanding of infection stages.

    Discussion:

    • HBV DNA integration into hepatocytes is a critical precursor to hepatocellular carcinoma.
    • Co-infection of Hepatitis B carriers with the delta agent presents complex challenges.
    • Unidentified causes of hepatitis, termed non-A, non-B, require further definition and diagnostic development.

    Key Insights:

    • Distinguishing viral hepatitis types is crucial for targeted diagnosis and treatment.
    • Understanding HBV's molecular mechanisms is key to preventing HBV-associated liver cancer.
    • The discovery of the delta agent highlights the complexity of viral hepatitis co-infections.

    Outlook:

    • Further research is needed to identify and diagnose non-A, non-B hepatitis agents.
    • Continued investigation into HBV integration mechanisms may reveal new therapeutic targets.
    • Developing comprehensive strategies for managing viral hepatitis, including co-infections, remains a priority.

    Related Experiment Videos